Clinical Trial Update: Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating intestinal decontamination with rifaximin in patients with liver cirrhosis and ascites, focusing on inflammatory and circulatory…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Liver Cirrhosis

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Copenhagen University Hospital, Hvidovre | Conditions: Liver Cirrhosis, Ascites | Phase 4 | Status: COMPLETED